A message from Emma France, Global CEO
In 2025, the Follicular Lymphoma Foundation continued to do what it was created to do: move faster, think differently, and refuse to accept follicular lymphoma as incurable.
This year marked a turning point. Scientific momentum accelerated. Global collaboration deepened. The patient voice grew louder. And real progress moved from theory into practice.
As I reflect on my first year as Global CEO, I am profoundly grateful to everyone who makes this work possible. Patients, caregivers, researchers, clinicians, donors, partners, advocates. You are driving change together.
This year, our community made it clear that we are done waiting. One piece of feedback captured exactly why this work matters:
I feel like I’ve been waiting so long to meet other people with the same struggle as me. For the first time, I know that ‘incurable but treatable’ is not good enough and that there is a team completely determined to find a cure.”
Shared a member of our FLF community
The highlights below show what happens when a community decides not to accept the status quo and chooses progress instead.
When I look back on 2025, these are the moments that best show what we achieved together.
1. Advancing research with real clinical impact
Across our scientific programmes, research continued to deliver results, influencing studies and trials and moving precision medicine forward through biomarker discovery and other high-impact work. What matters most is that this progress is helping shape better treatment for people living with FL.
2. Putting patients and community at the centre of the path to a cure
One of the most important things we did this year was listen. Through a global patient survey with more than 1,000 responses from 49 countries, ongoing workshops and webinars, and an in-person gathering in London, we heard directly from people living with FL. Their experiences, concerns, and priorities are shaping our focus and helping ensure progress is built around real lives and real needs.
3. Leading expert-driven progress toward cures
Working closely with scientists and clinicians, we strengthened our expert-informed approach by convening a Scientific Leadership Roundtable and seeking guidance on the research with the greatest potential impact. These insights help ensure our decisions remain focused on what can move us toward a cure fastest.
4. Elevating follicular lymphoma on the global stage
By hosting dedicated FL symposia at ICML and ASH, we placed follicular lymphoma at the heart of the international research agenda. These forums strengthened collaboration, accelerated shared learning, and ensured FL remains a priority within the world’s leading scientific communities.
5. Powered by partnership, generosity, and shared commitment
None of this progress would have been possible without partnership. I’m deeply grateful for the generosity of our community and for the many thoughtful conversations with donors, industry, and partners throughout the year. This shared commitment was reflected so powerfully in the Unlock the Cure gala, which raised more than £800,000 to accelerate research and breakthroughs.
6. Highlighting FL’s broader scientific significance
We strengthened understanding of why FL offers a unique opportunity to study how cancer develops, evades the immune system, and resists treatment. Because FL progresses slowly, insights gained here have the potential to shape future research approaches across many cancers.
The year ahead is even more ambitious. We are advancing work across research, collaboration, and emerging technologies, with one clear aim: to accelerate progress for people living with follicular lymphoma.
We will begin 2026 by hosting the first-ever global follicular lymphoma conclave in Barcelona. This event will bring together leaders in science, medicine, and technology to align on priorities and identify the most promising directions toward curing FL.
We are not imagining a cure. We are taking the next steps to reach it.
A gift today will help drive research forward, strengthen patient involvement, and move us closer to cures that do not yet exist. If you would like to help accelerate the next phase of this work, your support can make a real difference.
As Global CEO, I feel incredibly privileged to serve this community. Every conversation, every question, and every act of support reminds me that progress is never driven by one person or one institution, but by people choosing to stand together and push for something better. I am deeply grateful to everyone who has played a part in moving this work forward.
Thank you for being part of this journey
Thank you for refusing to wait.
Thank you for believing progress is possible.
Thank you for helping to change what the future looks like for people living with follicular lymphoma.
Together, we are creating a future where follicular lymphoma is no longer incurable.
Thank you for your support this year and for helping shape what comes next.
Emma France
Global CEO
Follicular Lymphoma Foundation
